Back
Gold Royalty Vs. Bright Minds Biosciences Industry Stock Comparison
Sell
37
GROY
Gold Royalty
Last Price:
$1.35
Seasonality Move:
-8.14%
Sell
37
DRUG
Bright Minds Biosciences
Last Price:
$37.50
Seasonality Move:
-32.13%
Sell
37
Gold Royalty (GROY)
is a Sell
Is Gold Royalty a Buy, Sell or Hold?
-
The current Gold Royalty [GROY] share price is $1.36. The Score for GROY is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
-
GROY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
37
Bright Minds Biosciences (DRUG)
is a Sell
Is Bright Minds Biosciences a Buy, Sell or Hold?
-
The current Bright Minds Biosciences [DRUG] share price is $37.39. The Score for DRUG is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
-
DRUG is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GROY Stock Price Chart
What is Gold Royalty's stock price today?
-
The Gold Royalty share price today is $1.36The current trend is moderately bearish and GROY is experiencing buying pressure, which is a positive indicator for future bullish movement.
DRUG Stock Price Chart
What is Bright Minds Biosciences's stock price today?
-
The Bright Minds Biosciences share price today is $37.39The current trend is relatively stagnant and DRUG is experiencing buying pressure, which is a positive indicator for future bullish movement.
GROY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.02 | Buy |
| Relative Strength Index (14 RSI): | 49.27 | Sell |
| Chaikin Money Flow: | 457134 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.28 - 1.46) | Sell |
| Bollinger Bands (100): | (1.23 - 1.43) | Buy |
DRUG Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.52 | Sell |
| Relative Strength Index (14 RSI): | 49.78 | Sell |
| Chaikin Money Flow: | 27952 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (32.12 - 42.26) | Buy |
| Bollinger Bands (100): | (24.86 - 48.56) | Buy |
GROY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.4 | Sell |
| 20-day SMA: | 1.41 | Sell |
| 50-day SMA: | 1.29 | Buy |
| 200-day SMA: | 1.39 | Sell |
| 8-day EMA: | 1.38 | Sell |
| 20-day EMA: | 1.38 | Sell |
| 50-day EMA: | 1.34 | Buy |
| 200-day EMA: | 1.4 | Sell |
DRUG Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 35.75 | Buy |
| 20-day SMA: | 38.76 | Sell |
| 50-day SMA: | 37.71 | Sell |
| 200-day SMA: | 18.92 | Buy |
| 8-day EMA: | 36.45 | Buy |
| 20-day EMA: | 37.51 | Sell |
| 50-day EMA: | 37.11 | Buy |
| 200-day EMA: | 24.13 | Buy |
Gold Royalty Earnings Growth & GROY Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.01 per share, and an increase next year of $0.03 per share.
Bright Minds Biosciences Earnings Growth & DRUG Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.12 per share, a decrease next quarter of $0.11 per share, a decrease this year of $0.77 per share, and a decrease next year of $1.55 per share.
Gold Royalty Technical Analysis
| Feb 13 | Feb 14 | Feb 18 | Feb 19 | Feb 20 | Feb 21 | Feb 25 | Feb 26 | Feb 27 | Feb 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb | ||||||||||
| 13 | 14 | 18 | 19 | 20 | 21 | 25 | 26 | 27 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Bright Minds Biosciences Technical Analysis
| Feb 13 | Feb 14 | Feb 18 | Feb 19 | Feb 20 | Feb 21 | Feb 25 | Feb 26 | Feb 27 | Feb 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb | ||||||||||
| 13 | 14 | 18 | 19 | 20 | 21 | 25 | 26 | 27 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||